H. Gozlan

9.6k total citations · 1 hit paper
120 papers, 8.2k citations indexed

About

H. Gozlan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, H. Gozlan has authored 120 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Cellular and Molecular Neuroscience, 76 papers in Molecular Biology and 12 papers in Organic Chemistry. Recurrent topics in H. Gozlan's work include Neuroscience and Neuropharmacology Research (83 papers), Neurotransmitter Receptor Influence on Behavior (53 papers) and Receptor Mechanisms and Signaling (48 papers). H. Gozlan is often cited by papers focused on Neuroscience and Neuropharmacology Research (83 papers), Neurotransmitter Receptor Influence on Behavior (53 papers) and Receptor Mechanisms and Signaling (48 papers). H. Gozlan collaborates with scholars based in France, Denmark and United States. H. Gozlan's co-authors include M. Hamon, Salah El Mestikawy, Daniel Vergé, Yehezkel Ben‐Ari, L. Pichat, Anne‐Marie Laporte, G. Daval, M.B. Emerit, J. Głowiński and C M Fattaccini and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

H. Gozlan

119 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT

1983 657 citations H. Gozlan, Salah El Mestikawy et al. profile →

Peers

Countries citing papers authored by H. Gozlan

Since Specialization

Citations

This map shows the geographic impact of H. Gozlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Gozlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Gozlan more than expected).

Fields of papers citing papers by H. Gozlan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Gozlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Gozlan. The network helps show where H. Gozlan may publish in the future.

Co-authorship network of co-authors of H. Gozlan

This figure shows the co-authorship network connecting the top 25 collaborators of H. Gozlan. A scholar is included among the top collaborators of H. Gozlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Gozlan. H. Gozlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Antiepileptic Drugs on Refractory Seizures in the Intact Immature Corticohippocampal Formation In Vitro 2003 ·Epilepsia ·Pascale Quilichini, Diabé Diabira, Catherine Chiron, Mathieu Milh, Yehezkel Ben‐Ari, H. Gozlan	40
2	Epileptiform activity but not synaptic plasticity is blocked by oxidation of NMDA receptors in a chronic model of temporal lobe epilepsy 1997 ·Epilepsy Research ·O. Quesada, J.C. Hirsch, H. Gozlan, Yehezkel Ben‐Ari, Christophe Bernard	10
3	Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse 1994 ·European Journal of Pharmacology ·Anne‐Marie Laporte, (unknown), H. Gozlan, Michel Hamon	84
4	Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat 1994 ·European Journal of Pharmacology ·Samir Haj‐Dahmane, Thierry Jolas, Anne‐Marie Laporte, H. Gozlan, Antonio López‐Farré, M. Hamon, Laurence Lanfumey	19
5	Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain 1994 ·Neuropharmacology ·H. Gozlan, Anne‐Marie Laporte, (unknown), Lee E. Schechter, (unknown), M. Hamon	40
6	(?)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain 1993 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Thierry Jolas, Samir Haj‐Dahmane, Laurence Lanfumey, C M Fattaccini, Emma J. Kidd, J. Adrien, H. Gozlan, Béatrice Guardiola‐Lemaître, M. Hamon	59
7	Anxiolytic-like actions of anpirtoline in a mouse light-dark aversion paradigm 1992 ·Neuroreport ·(unknown), Nicholas M. Barnes, B. Costall, H. Gozlan, M. Hamon, M.E. Kelly, Deborah Murphy, Robert J. Naylor	17
8	Quantification of 5-hydroxytryptamine1a receptors in the cerebellum of normal and X-irradiated rats during postnatal development 1992 ·Neuroscience ·Line Matthiessen, G. Daval, Yannick Bailly, H. Gozlan, M. Hamon, Daniel Vergé	20
9	Pharmacologie préclinique de l'amoxapine et de l'amitriptyline : implications des systèmes sérotoninergiques et opioïdergiques dans leurs effets centraux chez le rat 1991 ·H. Gozlan, (unknown), (unknown), Raúl Laguzzi, (unknown)	1
10	Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells 1991 ·Biochemical Pharmacology ·Marie‐Christine Miquel, M.B. Emerit, H. Gozlan, M. Hamon	12
11	The GTP‐Insensitive Component of High‐Affinity [³H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin Binding in the Rat Hippocampus Corresponds to an Oxidized State of the 5‐Hydroxytryptamine_1A Receptor 1991 ·Journal of Neurochemistry ·M.B. Emerit, Marie‐Christine Miquel, H. Gozlan, M. Hamon	22
12	The Central 5‐HT_1A Receptors: Pharmacological, Biochemical, Functional, and Regulatory Properties^a 1990 ·Annals of the New York Academy of Sciences ·M. Hamon, H. Gozlan, Salah El Mestikawy, M.B. Emerit, (unknown), Lee E. Schechter	130
13	Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide 1990 ·Neuroscience Letters ·Salah El Mestikawy, Mustapha Riad, Anne‐Marie Laporte, Daniel Vergé, G. Daval, H. Gozlan, M. Hamon	87
14	Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact? 1989 ·European Journal of Pharmacology ·Daniël Hoyer, H. Gozlan, (unknown), Lee E. Schechter, M. Hamon	47
15	Chromatographic Analyses of the Serotonin 5‐HT_1A Receptor Solubilized from the Rat Hippocampus 1989 ·Journal of Neurochemistry ·Salah El Mestikawy, Delphine Taussig, H. Gozlan, M.B. Emerit, M. Ponchant, M. Hamon	18
16	Altered Balance between Thyrotropin-Releasing Hormone and Dopamine in Prolactinomas and Other Pituitary Tumors Compared to Normal Pituitaries 1989 ·The Journal of Clinical Endocrinology & Metabolism ·M. Le Dafniet, (unknown), H. Gozlan, Alain Barret, D. Bression, F Peillon	13
17	Pharmacological and Biochemical Characterization of Rat Hippocampal 5‐Hydroxytryptamine_1A Receptors Solubilized by 3–[3–(Cholamidopropyl)dimethylammonio]‐1‐Propane Sulfonate (CHAPS) 1988 ·Journal of Neurochemistry ·Salah El Mestikawy, Christophe Cognard, H. Gozlan, M. Hamon	16
18	Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to d-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens 1988 ·Brain Research ·H. Simon, Khalid Taghzouti, H. Gozlan, Jeanne‐Marie Studler, Alain Louilot, Denis Hervé, J. Głowiński, Jean‐Pol Tassin, Michel Le Moal	113
19	The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino) chroman 1987 ·European Journal of Pharmacology ·(unknown), H. Gozlan, Umberto Spampinato, (unknown), Gérald Guillaumet, L. Pichat, M. Hamon	43
20	Chronic Chlorimipramine Does Not Reverse the Reduction of Cerebrospinal Fluid Met-Enkephalin-Like Immunoreactivity in Chronic-Pain Patients 1987 ·Clinical Neuropharmacology ·S. Bourgoin, F. Cesselin, H. Gozlan, C M Fattaccini, M. A. Tran, J L Montastruc, A Rascol, M. Hamon	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact